IL-6 deficiency leads to increased emotionality in mice: Evidence in transgenic mice carrying a null mutation for IL-6

Journal of Neuroimmunology

Volumn 92, Issue 1-2, 1998, Pages 160-169

  Armario, Antonio ^a   Hernández, Joaquín ^a   Bluethmann, Horst ^b   Hidalgo, Juan ^a  

^a Depto de Biol Cel Y Fisiol F   (Spain)

^b Gene Technologies   (Switzerland)

Author keywords

Cytokines; Emotionality; Holeboard; IL 6 deficiency; Knock out mice; Plus maze

Indexed keywords

INTERLEUKIN 6;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EMOTIONALITY; GENE; GENE MUTATION; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BEHAVIOR, ANIMAL; EMOTIONS; EXPLORATORY BEHAVIOR; INTERLEUKIN-6; MAZE LEARNING; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTATION; SEXUAL BEHAVIOR, ANIMAL;

EID: 0344141247     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00199-4     Document Type: Article

References (64)

1. Andersson P., Perry V., Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience. 48:1992;169-186.
2. Archer J. Tests for emotionality in rats and mice: a review. Anim. Behav. 21:1973;205-235.
3. Arend W.P. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J. Clin. Invest. 88:1991;1445-1451.
4. Armario A., López Calderón A., Jolín T., Castellanos J. Sensitivity of anterior pituitary hormones to graded levels of psychological stress. Life Sci. 39:1986;471-475.
5. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Yolk B., Berger M. Interleukin-6 and alpha-2-macroglubulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285:1991;111-114.
6. Bouchard T.J. Genes, environment, and personality. Science. 264:1994;1700-1701.
7. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B.A., Mucke L. Neurologic disease in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA. 90:1993;10061-10065.
8. Chen C., Rainnie D., Greene R., Tonegawa S. Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II. Science. 266:1994;291-294.
9. Dunn A., Berridge C. Physiological and behavioral responses to corticotrophin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:1990;71-100.
10. File S.E., Wardill A.G. Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacologia. 44:1975;53-59.
11. Frei K., Leist T., Meager A., Gallo P., Leppert D., Zinkernagel R., Fontana A. Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. J. Exp. Med. 168:1988;449-453.
12. Gadient R.A., Otten U. Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci. Lett. 153:1993;13-16.
13. Gadient R.A., Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res. 637:1994;10-14.
14. Gadient R.A., Otten U. Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci. Lett. 182:1994;243-246.
15. Gallo P., Fre K., Rordorf C., Lazdins J., Tavolato B., Fontana A. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23:1989;109-116.
16. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci. 19:1996;177-186.
17. Hama T., Miyamoto M., Tsukui H., Nishio C., Hatanaka H. Interleukin 6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats. Neurosci. Lett. 104:1989;340-344.
18. Hama T., Kushima Y., Miyamoto M., Kubota M., Takei N., Hatanaka H. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience. 40:1991;445-452.
19. Haour, F., Ban, E., Marquette, C., Milon, G., Fillion, G., 1992. Brain interleukin-1 receptors: mapping, characterization and modulation. In: Rothwell, N., Dantzer, R. (Eds.), Interleukin-1 in the Brain, Pergamon, Oxford, pp. 13-25.
20. Hennessy M., Levine S. Sensitive pituitary adrenal responsiveness to varying intensities of psychological stimulation. Physiol. Behav. 21:1978;295-297.
21. Heyser C.J., Masliah E., Samimi A., Campbell I.L., Gold L.H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. Natl. Acad. Sci. USA. 94:1997;1500-1505.
22. Hofman F., Hinton D., Johnson K., Merrill J. Tumor necrosis factor identified in multiple-sclerosis brain. J. Exp. Med. 170:1989;607-612.
23. Hopkins S., Rothwell N. Cytokines and the nervous system: I. Expression and recognition. Trends Neurosci. 18:1995;83-88.
24. Houssiau F., Bukasa K., Sindic C., van Dammes J., van Snick J. Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin. Exp. Immunol. 71:1988;320-323.
25. Janz L.J., Brown R., Zuo L., Falk J., Greenberg A.H., Dyck D.G. Conditioned taste aversion but not adrenal activity develops to icv administration of interleukin-1 in rats. Physiol. Behav. 49:1991;691-694.
26. König M., Zimmer A.M., Steiner H., Holmes P.V., Crawley J.N., Brownstein M.J., Zimmer A. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature. 383:1996;535-538.
27. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 368:1994;339-342.
28. Kulkarni S.K., Sharma A.C. Elevated plus-maze: a novel psychobehavioral tool to measure anxiety in rodents. Methods Find. Exp. Clin. Pharmacol. 13:1991;573-577.
29. LeMay L.G., Vander A.J., Kluger M.J. The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol. Behav. 47:1990;957-961.
30. Li A.-J., Katafuchi T., Oda S., Hori T., Oomura Y. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res. 748:1997;30-38.
31. Licinio J., Wong M.L., Gold P.W. Localization of interleukin-1 receptor antagonist mRNA in rat brain. Endocrinology. 129:1991;562-564.
32. Lister R. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
33. Maier S.F., Watkins L.R. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res. 695:1995;279-282.
34. Maier S.E., Vandenhoff P., Crowne D.P. Multivariate analysis of putative measures of activity, exploration, emotionality, and spatial behavior in the hooded rat (Rattus norvegicus). J. Comp. Psychol. 102:1988;378-387.
35. Mandrup-Poulsen T., Nerup J., Reimers J., Pociot F., Andersen H., Karlsen A., Bjerre U., Bergholdt R. Cytokines and the endocrine system: I. The immunoendocrine network. Eur. J. Endocrinol. 133:1995;660-671.
36. Merrill J.E., Jonakait G.M. Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease. FASEB J. 9:1995;611-618.
37. Minami M., Kuraishi Y., Yamaguchi T., Nakai S., Hirai Y., Satoh M. Immobilization stress induces interleukin-1b mRNA in the rat hypothalamus. Neurosci. Lett. 123:1991;254-256.
38. Montkowski A., Landgraf R., Yassouridis A., Holsboer F., Schöbitz B. Central administration of IL-1 reduces anxiety and induces sickness behaviour in rats. Pharmacol. Biochem. Behav. 58:1997;329-336.
39. Montkowski A., Poettig M., Mederer A., Holsboer F. Behavioural performance in three substrains of mouse strain 129. Brain Res. 762:1997;12-18.
40. Pousset F. Cytokines as mediators in the central nervous system. Biomed. Pharmacother. 48:1994;425-431.
41. Qiu Z., Parsons K.L., Gruol D.L. Interleukin-6 selectively enhances the intracellular calcium response to NMDA in developing CNS neurons. J. Neurosci. 15:1995;6688-6699.
42. Raber J., O'Shea R., Bloom F., Campbell I. Modulation of hypothalamic-pituitary-adrenal function by transgenic expression of interleukin-6 in the CNS of mice. J. Neurosci. 17:1997;9473-9480.
43. Ringheim G.E., Burgher K.L., Heroux J.A. Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brain. J. Neuroimmunol. 63:1995;113-123.
44. Rochford J., Beaulieu S., Rousse I., Glowa J., Barden N. Behavioral reactivity to aversive stimuli in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: effects of diazepam and FG-7142. Psychopharmacology. 132:1997;145-152.
45. Rothwell N.J. Functions and mechanisms of interleukin 1 in the brain. Trends Physiol. Sci. 12:1991;430-436.
46. Rothwell N.J., Hopkins S.J. Cytokines and the nervous system: II. Actions and mechanisms of action. Trends Neurol. Sci. 18:1995;130-136.
47. Royce J.R. On the construct validity of open-field measures. Psychol. Bull. 84:1977;1098-1106.
48. Satoh T., Nakamura S., Taga T., Matsuda T., Hirano T., Kishimoto T., Kaziro Y. Induction of neuronal differentiation of PC12 cells by B cell stimulatory factor 2/interleukin 6. Mol. Cell. Biol. 8:1988;3546-3549.
49. Schöbitz B., de Kloet E.R., Sutanto W., Holsboer F. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur. J. Neurosci. 5:1993;1426-1435.
50. Schöbitz B., Van Den Dobbelsteen M., Holsboer F., Sutanto W., De Kloet E.R. Regulation of IL-6 gene expression in rat. Endocrinology. 132:1993;1569-1576.
51. Schöbitz B., Holsboer F., de Kloet E.R. Cytokines in the healthy and diseased brain. Neur. Physiol. Sci. 9:1994;138-142.
52. Sibilia M., Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:1995;234-238.
53. Soszynski D., Kozak W., Conn C., Rudolph K., Kluger M. Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field. Neuroendocrinology. 63:1996;459-467.
54. Stenzel-Poore M., Heinrichs S., Rivest S., Koob G., Vale W. Overproduction of corticotrophin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14:1994;2579-2584.
55. Tachibana T. Higher reliability and closer relationship between open-field test measures on aggregation data. Anim. Learn. Behav. 13:1985;345-348.
56. Takahashi J.S., Pinto L.H., Vitaterna M.H. Forward and reverse genetic approaches to behavior in the mouse. Science. 264:1994;1724-1733.
57. Takaki A., Huang Q.-H., Somogyvári-V A., Arimura A. Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines. Neuroimmunomodulation. 1:1994;335-342.
58. Takao T., Hashimoto K., De Souza E.B. Modulation of interleukin-1 receptors in the brain-endocrine-immune axis by stress and infection. Brain Behav. Immun. 9:1995;276-291.
59. Threadgill D.W., Dlugosz A.A., Hansen L.A., Tennembaum T., Lichti U., Yee D., LaMantia C., Mourton T., Herrup K., Harris R.C., Barnard J.A., Yuspa S.H., Coffey R.J., Magnuson T. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 269:1995;230-234.
60. Trullas R., Skolnick P. Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology. 111:1993;323-331.
61. Wagner J.A. Is IL-6 both a cytokine and a neurotrophic factor? J. Exp. Med. 183:1996;2417-2419.
62. Walsh R.N., Cummins R.A. The open-field test: a critical review. Psychol. Bull. 83:1976;482-504.
63. Woodrofe M., Sarna G., Wadhwa M., Hayes G., Loughlin A., Tinker A., Cuzner M. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33:1991;227-236.
64. Zhou D., Kusnecov A.W., Shurin M.R., DePaoli M., Rabin B.S. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 133:1993;2523-2530.